Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma

American Journal of Dermatopathology

Volumn 20, Issue 5, 1998, Pages 453-458

  Binder, Michael ^a,b   Steiner, Andreas ^a   Mossbacher, Ulli ^a   Hunegnaw, Mesfin ^a   Pehamberger, Hubert ^a   Wolff, Klaus ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Keratoacanthoma; Squamous cell carcinoma; Volume weighted mean nuclear volume (V (v))

Indexed keywords

ADULT; AGED; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATOACANTHOMA; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STEREOLOGY;

AGED; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KARYOMETRY; KERATOACANTHOMA; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0031657791     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199810000-00004     Document Type: Article

References (37)

1. Ackerman AB, Niven JM, Grant-Kels JM. Differential diagnosis in dermatopathology. Vol. I. Philadelphia: Lea & Febiger, 1982;122.
2. Chalet MD, Connors RC, Ackerman AB. Squamous cell carcinoma vs. keratoacanthoma: criteria for histologic differentiation. J Dermatol Surg 1975;1:16-7.
3. Lever WF, Schaumburg-Lever G. Tumors and cysts of the epidermis. Histopathology of the skin. 7th ed. Philadelphia: Lippincott, 1990;523-77.
4. Patel A, Halliday GM, Cooke BE, Barnetson RS. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994; 131:789-98.
5. Ramselaar CG, van-der MJ. The spontaneous regression of keratoacanthoma in man. Acta Derm Venereol 1976;56:245-51.
6. Gundersen HJ, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988;96:379-94.
7. Sorensen FB, Ottosen PD. Stereological estimation of nuclear volume in benign and malignant melanocytic lesions of the skin. Interand intraobserver variability of malignancy grading. Am J Dermatopathol 1991;13:99-107.
8. Gundersen HJ, Jensen EB. Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 1985;138:127-42.
9. Binder M, Dolezal I, Wolff K, Pehamberger H. Stereological estimation of volume weighted mean nuclear volume as a predictor of prognosis in 'thin' malignant melanoma. J Invest Dermatol 1992;99:180-3.
10. Sorensen FB, Kristensen IB, Grymer F, Jakobsen A. DNA level, tumor thickness, and stereological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact. Am J Dermatopathol 1991;13:11-9.
11. Steiner A, Binder M, Mossbacher U, Wolff K, Pehamberger H. Estimation of the volume-weighted mean nuclear volume discriminates Spitz's nevi from nodular malignant melanoma. Lab Invest 1994;70:381-5.
12. Sorensen FB, Bichel P, Jakobsen A. Stereological estimates of nuclear volume in squamous cell carcinoma of the uterine cervix and its precursors. Virchows Arch A Pathol Anat Histopathol 1991; 418:225-33.
13. Sasaki M, Sorensen FB, Fukuzawa S, Yamabe H, Olsen S, Yoshida O. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder. Cancer 1993;72:2470-83.
14. Ackerman AB, Ragaz A. The lives of lesions. New York: Masson, 1984;102-9.
15. Baddely AJ, Gundersen HJ, Cruz-Orive LM. Estimation of surface area from vertical sections. J Microsc 1986;142:259-76.
16. Metz CE. Some practical issues of experimental design and data analysis in radiological ROC studies. Invest Radiol 1989;24:234-45.
17. LeBoit PE. Is keratoacanthoma a variant of squamous cell carcinoma? New insights into an old controversy . . . soon? [editorial; comment]. Am J Dermatopathol 1995;17:319-20.
18. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol 1993;15:332-42.
19. Kerschmann RL, McCalmont TH, LeBoit PE. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol 1994;130:181-6.
20. Miracco C, De Santi MM, Lio R, Biagioli M, Tosi P, Luzi P. Quantitatively evaluated ultrastructural findings can add to the differential diagnosis between keratoacanthoma and well differentiated squamous cell carcinoma. J Submicrosc Cytol Pathol 1992; 24:315-21.
21. Toriyama F. Correlation between electron microscopic nuclear irregularity index and malignancy of epidermal tumors. Nippon Hifuka Gakkai Zasshi 1990;100:37-47.
22. Krunic AL, Garrod DR, Smith NP, Orchard GS, Cvijetic OB. Differential expression of desmosomal glycoprotein in keratoacanthoma and squamous cell carcinoma of the skin - an immunohistochemical aid to diagnosis. Acta Dermatol Venereol 1996;76: 394-8.
23. Phillips P, Helm KF. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma. J Cutan Pathol 1993;20:424-8.
24. Royds JA, Stephenson TJ, Silcocks PB, Bleehen SS. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin. Pathologica 1994;86:612-6.
25. Schaumburg L, Alroy J, Ucci A, Lever WF. Cell surface carbohydrates in proliferative epidermal lesions. II. Masking of peanut agglutinin (PNA) binding sites in solar keratoses, Bowen's disease, and squamous cell carcinoma by neuraminic acid. J Cutan Pathol 1986;13:163-71.
26. Skalova A, Michal M. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in formalin-fixed paraffin sections. Am J Dermatopathol 1995:17:332-4.
27. Stephenson TJ, Royds JA, Bleehen SS, Silcocks PB, Rees RC. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma. Dermatology 1993;187:95-9.
28. Kanitakis J, Hoyo E, Hermier C, Chouvet B, Thivolet J. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin. Cancer 1992;69:2937-41.
29. Seidman JD, Berman JJ, Moore GW, Yetter RA. Multiparameter DNA flow cytometry of keratoacanthoma. Anal Quant Cytol Histol 1992;14:113-9.
30. Waring AJ, Takata M, Rehman I, Rees JL. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 1996;73:649-53.
31. Corominas M, Leon J, Kamino H, Cruz A, Novick SC, Pellicer A. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Oncogene 1991;6:645-51.
32. Sorensen FB. Quantitative analysis of nuclear size for objective malignancy grading: a review with emphasis on new, unbiased stereologic methods. Lab Invest 1992;66:4-23.
33. Sorensen FB, Gamel JW, Mccurdy J. Stereologic estimation of nucleolar volume in ocular melanoma: a comparative study of size estimators with prognostic impact. Hum Pathol 1993;24:513-8.
34. Huang MS, Colby TV, Therneau TM, Daly RC, Gonchoroff NJ. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry. Cytometry 1996;26:253-9.
35. Nielsen K, Overgaard J, Bentzen SM, Bruun E. Histological grade, DNA ploidy and mean nuclear volume as prognostic factors in prostatic cancer. APMIS 1993;101:614-20.
36. Martin R, Nieto S, Santamaria L. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression. Gen Diagn Pathol 1997;143: 29-38.
37. Vogt T, Zipperer KH, Vogt A, Holzel D, Landthaler M, Stolz W. p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin. Histopathology 1997;30:57-63.